France's Therapeutic Part-Time Work After Cancer: The Rights Most Employees Never Use

How France's Gradual Return-to-Work System Works After Cancer

France has built a legal framework to help cancer survivors return to work gradually rather than all at once, but the gap between what the law offers and what employees actually use is wide. Each year, more than 433,000 new cancer cases are diagnosed in France, and nearly 40% of patients are employed at the time of diagnosis, according to the Institut national du cancer. Five years later, 63.5% still live with after-effects, and one in five workers has lost their job along the way.

The law provides three main tools. Before sick leave even ends, an employee can request a pre-return visit with the occupational physician to plan adjustments. Since 2022, a supervised trial (essai encadré) allows a two-week return to the job without interrupting sick leave or losing benefits. The most substantial mechanism is therapeutic part-time, which lets an employee return at 50%, 60% or 80% of normal hours. A treating doctor prescribes it, the employer must agree (though refusal is possible for operational reasons), and the Assurance maladie pays daily allowances — capped at €42.97 per day — to offset lost salary. For cancer, classified as a long-term condition, this compensation can last up to three years, extendable by one year.

The take-up, however, is low. Only about one quarter of employees who were working at diagnosis used therapeutic part-time, according to the VICAN5 survey. The reasons are partly social: part-time work is visible, requires justification to managers, and shifts workload onto colleagues. A separate survey by training organization Fasterclass, conducted in September with 2,913 workers including 1,198 managers, found that 30% of managers cited pressure to resume at the same pace as before, and 29% of employees said they were viewed differently after returning.

A final lever exists but carries stigma: recognition as a disabled worker (travailleur handicapé). This status, granted by the MDPH, opens access to workstation and schedule adjustments that Agefiph can co-finance. Employees are not obliged to inform their employer, but if they do, the company must implement accommodations. Many hesitate because the label feels permanent — a concern the article illustrates through Sophie, a manager who initially refused the status before a relapse changed her mind.

Why the 'Back to Normal' Myth Costs Employers and Employees

Why the Data Favors Therapeutic Part-Time — and Why Employees Still Avoid It

The VICAN5 figures make a clear case: five years after diagnosis, 84.6% of therapeutic part-time users are still employed, compared with 68% of those who did not use it. That 16.6-point gap is the strongest argument for the mechanism. Yet only about a quarter of eligible workers take it up. The barrier is not legal availability but workplace culture. Part-time work is visible, invites questions, and forces colleagues to absorb extra workload. In environments that have not adapted to illness, the employee often chooses to overcompensate rather than appear diminished.

The 'Status Risk' That No HR Policy Captures

Catherine Tourette-Turgis, professor emerita at Sorbonne Université and founder of the Université des patients, describes a subtler danger than dismissal: 'status risk.' This is the quiet removal of files 'as a precaution,' the meetings to which no one invites you anymore. It is a loss of recognition with no formal decision, making it nearly impossible to prove because it hides behind apparent benevolence. For managers returning after cancer, the pressure is double: reassure hierarchy of capacity while proving to teams they remain available. The Fasterclass survey quantifies this — 30% of managers name the pressure to resume at the same pace as a top difficulty.

What Employers Gain by Supporting Gradual Return

For context, France's approach sits within a broader European trend of treating cancer survivorship as a workplace retention issue rather than a purely medical one. The business case is straightforward: replacing an experienced manager carries recruitment and training costs, and the VICAN5 data suggests gradual return significantly improves retention. Employers that facilitate therapeutic part-time, pre-return visits, and accommodations preserve institutional knowledge and reduce long-term hiring expenses. The obstacle is often managerial habit — a preference for full-time presence — rather than formal policy.

The Disabled Worker Status: A Powerful but Stigmatized Tool

Recognition as a disabled worker unlocks accommodations that therapeutic part-time alone does not: workstation adjustments, schedule flexibility, and Agefiph co-financing. Crucially, employees can obtain the status without informing their employer. But the word 'handicap' carries weight in French workplace culture, and many fear it will follow them after recovery. The article's account of Sophie — who rejected the status for years before a relapse prompted her to pursue it — illustrates how stigma delays access to the very protections designed to help.

What Employees and Managers Should Know Before a Cancer Return

The most important insight: France's therapeutic part-time system is underused not because it is unavailable, but because employees fear the social cost of visible accommodation — even though data shows it dramatically improves long-term job retention.

For employees returning after cancer:

• Request a pre-return visit with the occupational physician before your sick leave ends to plan adjustments in advance.
• Ask your treating doctor about therapeutic part-time at 50%, 60% or 80% — the Assurance maladie pays up to €42.97 per day, and for cancer (a long-term condition) compensation can last up to three years, extendable by one year.
• Check whether your collective agreement or prévoyance tops up the daily allowance to full salary.
• Consider requesting disabled worker status from the MDPH — you are not obliged to inform your employer, but if you do, the company must implement accommodations that Agefiph can co-finance.

For managers and HR teams:

• Proactively discuss gradual return options before the employee returns; 30% of managers report pressure to resume at the same pace, which drives relapse and turnover.
• Plan workload redistribution when an employee returns part-time so colleagues are not silently penalized — this is a key reason employees avoid the mechanism.
• Watch retention metrics at the 12- and 24-month marks for employees who returned after long-term illness; the VICAN5 data suggests this is where the 84.6% versus 68% employment gap materializes.